Skip to content

13F-HR filed by Omega Fund Management, LLC

Omega Fund Management, LLC filed this 13F-HR for the quarter ended 2025-03-31, filed 2025-05-15, with 13 holding rows worth $169,462,464.

Accession
0000950123-25-005509
Filed
2025-05-15
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q1 2025

A holdings report, 13 entries on the cover page, a total value of $169,462,464 stated on the cover page (in dollars after the unit check, H1), rows summing to $169,462,464 with VALUE read as dollars as filed, 13F file number 028-16844. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
KESTRA MED TECHNOLOGIES LTDG52441105SHS1,795,893$44,753,654dollars as filed
BICARA THERAPEUTICS INC055477103COM2,204,650$28,726,590dollars as filed
BETA BIONICS INC08659B102COMMON STOCK1,988,287$24,336,633dollars as filed
NUVATION BIO INC COM CL A67080N101Stock13,072,340$23,007,318dollars as filed
REPLIMUNE GROUP INC76029N106COMMON STOCK1,975,203$19,258,229dollars as filed
UPSTREAM BIO INC91678A107COMMON STOCK2,036,293$12,462,113dollars as filed
LEXEO THERAPEUTICS INC52886X107COMMON STOCK1,184,636$4,110,687dollars as filed
ALUMIS INC022307102COM653,223$4,010,789dollars as filed
IKENA ONCOLOGY INC45175G108COM2,249,123$2,878,877dollars as filed
ENGENE HOLDINGS INC29286M105COM526,357$2,358,079dollars as filed
IMMUNIC INC4525EP101COM1,788,160$1,949,094dollars as filed
SANA BIOTECHNOLOGY INC799566104COM843,750$1,417,500dollars as filed
ENGENE HOLDINGS INC29286M113W EXP 10/31/2028321,502$192,901dollars as filed

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0000950123-25-005509this filing2025-05-15acceptance time not in the bulk data set